SecBot SecBot
SECBOTREPLAY Home › Report › DYN

DYN · John Cox, an officer of Dyne Therapeutics, filed a Form 144 notice of…

Dyne Therapeutics, Inc. · 144 filed Nov 13, 2026 at 16:05 ET

At the news

NEUTRALIMPACT 2/10

144 filed Nov 13, 2026 at 16:05 ET

John Cox, an officer of Dyne Therapeutics, filed a Form 144 notice of intent to sell 5,513 shares of common stock, with an estimated aggregate market value of approximately $92,751 based on a price of $16.82 per share. The sale is related to the vesting of restricted stock units and represents a routine insider transaction for tax or diversification purposes.

  • Reporting person: John Cox, an officer of Dyne Therapeutics
  • Shares to be sold: 5,513 shares of common stock
  • Estimated aggregate market value: $92,751 (based on $16.82 per share)
  • Sale intended on or about 11/13/2026

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access